×
Back to Agenda
[Session 6] Drug Induced Cardiovascular and Hemodynamic Changes
Session Chair(s)
Koki Nakamura, MD, PHD
Vice President, CVM Marketing, Japan Pharma Business Unit, Takeda Pharmaceutical Company Limited, Japan
Kaori Shinagawa, MD, PHD
Senior Scientist for Clinical Medicine, Office of New Drug II, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Shinichiro Ueda, MD, PHD
Professor of Clinical Pharmacology & Therapeutics, University of the Ryukyus, Japan
Cardiac Safety of Drug Treatment in Patient with Common Co Morbidities (Hypertension Hyperlipidemia DM)
Jeff Heilbraun, MS
Vice President, Medical and Scientific Affairs, Cardiology, Clario, United States
Advanced Hemodynamic Monitoring in Clinical Trials
Colette Strnadova, PHD
Senior Scientific Advisor, Therapeutic Products Directorate, Health Canada, Canada
Regulatory Update on Drug-Induced Blood Pressure Effects
Have an account?